Rocuronium Bromide

CAS 119302-91-9 12 current records 3 historicalSmall Molecule

Who holds supplier records for Rocuronium Bromide? 12 organisations hold a current record for Rocuronium Bromide: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability (11 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (3), China (3), Netherlands (2), Italy (1) and 2 other countries (2); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Rocuronium Bromide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/rocuronium-bromide

Reading the evidence

  • 12 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (12)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Rocuronium Bromide. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Rocuronium Bromide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (11)

Certificates of Suitability on the EDQM register for Rocuronium Bromide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
FARMHISPANIA S.A. MontmeloES
CEP 2023-131 - Rev 03
Rocuronium bromide, Process II
Jul 2026Inspected May 2023
Spain, outside 3-year window
GLAND PHARMA LIMITED VisakhapatnamIN
CEP 2023-174 - Rev 00
Rocuronium bromide
Dec 2025—
MANKIND PHARMA LIMITED New DelhiIN
CEP 2024-337 - Rev 00
Rocuronium bromide
Aug 2025—
ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2025-319 - Rev 00
Rocuronium bromide, Process II
Aug 2025—
SHANGHAI JUNMED HEALTHCARE CO., LTD ShanghaiCN
CEP 2023-169 - Rev 00
Rocuronium bromide
May 2025—
TAPI NL B.V. AmsterdamNL
CEP 2010-023 - Rev 06
Rocuronium bromide
Mar 2025—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. LinhaiCN
CEP 2024-267 - Rev 00
Rocuronium bromide, Acetone process
Sept 2024Inspected May 2026
Italy
CURIA ITALY S.R.L. Rozzano, MilanoIT
CEP 2015-113 - Rev 01
Rocuronium bromide
Apr 2024Inspected Dec 2024
Italy
ASPEN OSS B.V. OssNL
R1-CEP 2009-231 - Rev 02
Rocuronium bromide
Nov 2022—
Farmhispania, S.A. MontmelóES
R1-CEP 2006-176 - Rev 02
Rocuronium bromide
Aug 2022—
ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. XianjuCN
R1-CEP 2013-065 - Rev 01
Rocuronium bromide
May 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Rocuronium Bromide are no longer active. These show a past filing, not current supply.

Show all 3 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Rocuronium Bromide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200648).

Chemical identity

IUPAC name
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate bromide
Canonical SMILES
CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-]
InChIKey
OYTJKRAYGYRUJK-FMCCZJBLSA-M
Synonyms
Bromure de rocuronium, Bromuro de rocuronio, Esmeron, ORG 9426, ORG-9426, Rocuronium bromide, Zemuron, org9426, CHEBI:8885, rocuronii bromidum, RefChem:56464, M03AC09

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Nondepolarizing Neuromuscular Blocker
Physiologic effect
Neuromuscular Nondepolarizing Blockade

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Rocuronium Bromide?

12 organisations hold an active US FDA Type II Drug Master File or a CEP for Rocuronium Bromide: ASPEN OSS BV (Netherlands), CURIA ITALY SRL (Italy), FARMHISPANIA SA (Spain), GLAND PHARMA LTD (India), Mankind Pharma Limited (India), SHANGHAI JUNMED HEALTHCARE CO LTD (China), TAPI NL BV (Netherlands) and Zhejiang Huahai Pharmaceutical Co., Ltd. (China), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Rocuronium Bromide Drug Master Files are active?

ASPEN OSS BV (DMF 9854), CURIA ITALY SRL (DMF 34252), FARMHISPANIA SA (DMF 19819), GLAND PHARMA LTD (DMF 20833), Mankind Pharma Limited (DMF 39437), SHANGHAI JUNMED HEALTHCARE CO LTD (DMF 37698), TAPI NL BV (DMF 20068) and Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 29741) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Rocuronium Bromide records mean?

3 organisations have only inactive Type II DMFs for Rocuronium Bromide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Rocuronium Bromide have a European Certificate of Suitability?

Yes. 9 organisations hold a valid CEP for Rocuronium Bromide on the EDQM register, including FARMHISPANIA S.A. Montmelo (ES), GLAND PHARMA LIMITED Visakhapatnam (IN), MANKIND PHARMA LIMITED New Delhi (IN), ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou (CN), SHANGHAI JUNMED HEALTHCARE CO., LTD Shanghai (CN) and TAPI NL B.V. Amsterdam (NL) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Rocuronium Bromide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Rocuronium Bromide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.